#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ehlers-Danlos syndrome Acquired ATTR amyloidosis Extra-osseous Ewing's sarcoma metastatic Fatty acid oxidation disorder Gastric cancer Cerebral amyloid angiopathy Langerhans cell sarcoma Chemical burn Fragile X syndrome Endocrine ophthalmopathy Neuroendocrine carcinoma of the skin Sexually transmitted disease Prolymphocytic leukaemia Dent's disease Wiskott-Aldrich syndrome More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Usher’s syndrome – Diagnostics Skin angiosarcoma – Basic Information Phenylketonuria Angelman’s syndrome – Life with Disease Ornithine transcarbamoylase deficiency Amyotrophic lateral sclerosis – Trials in Disease Marginal zone lymphoma refractory – Trials in Disease Leiomyosarcoma recurrent – Treatment Waldenstrom’s macroglobulinaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Trastuzumab ZUNIBERGENE ROCPARVOVEC Human Plasma Protein VTX-002 Codeine Phosphate Nitrous Oxide Acetylcysteine Linagliptin PHENTOLAMINE MESILATE Haloperidol Decanoate [11C]Az14193391 Phenobarbital MEGESTROL ACETATE Methylprednisolone Acetate Caspofungin Fludrocortisone Acetate Nms-03305293 GOLD SODIUM THIOSULFATE Prednisone Masitinib More therapies…

    Learn about Your Condition

    Obliterative bronchiolitis Diminished ovarian reserve Ovarian granulosa cell tumour Precocious puberty Haemofiltration Mucopolysaccharidosis III Hypoaesthesia Glomerulonephritis membranous Ventricular extrasystoles Brain injury Endolymphatic hydrops Chronic hepatitis C Biliary neoplasm Von Hippel-Lindau disease Cystic fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Rhinoto Kft.

Rhinoto Kft.

Varady Antal Utca 10/a, Fsz 4-5 Ajto, Pecs, 7621, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Lebrikizumab
    • Mometasone Furoate
    Belgium Bulgaria Denmark Finland Germany Hungary +5

  • Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Itepekimab
    Austria Finland Germany Hungary Italy The Netherlands +4

  • Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

    Not recruiting

    3 1
    Investigated Drugs:
    • Itepekimab
    Austria Belgium Czechia Denmark Finland France +9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!